Loratadine Impurity 17, with the CAS number 133330-72-0, is a chemical compound that is recognized as an impurity associated with the antihistamine drug loratadine. This substance is typically characterized by its molecular structure, which may include specific functional groups that differentiate it from the parent compound. Impurities like Loratadine Impurity 17 can arise during the synthesis of loratadine and may affect the purity and efficacy of the final pharmaceutical product. The compound is generally analyzed using techniques such as high-performance liquid chromatography (HPLC) to quantify its presence and assess its impact on drug quality. While specific physical and chemical properties such as melting point, solubility, and spectral data may vary, impurities are often characterized by their stability, reactivity, and potential biological activity. Understanding the characteristics of such impurities is crucial for pharmaceutical development and regulatory compliance, ensuring that the final drug formulation meets safety and efficacy standards.

Loratadine Impurity 17

133330-72-0: Loratadine Impurity 17, with the CAS number 133330-72-0, is a chemical compound that is recognized as an impurity associated with the antihistamine drug loratadine. This substance is typically characterized by its molecular structure, which may include specific functional groups that differentiate it from the parent compound. Impurities like Loratadine Impurity 17 can arise during the synthesis of loratadine and may affect the purity and efficacy of the final pharmaceutical product. The compound is generally analyzed using techniques such as high-performance liquid chromatography (HPLC) to quantify its presence and assess its impact on drug quality. While specific physical and chemical properties such as melting point, solubility, and spectral data may vary, impurities are often characterized by their stability, reactivity, and potential biological activity. Understanding the characteristics of such impurities is crucial for pharmaceutical development and regulatory compliance, ensuring that the final drug formulation meets safety and efficacy standards.

CAS 133330-72-0

Loratadine Impurity 17

Loratadine Impurity 17

Ref: 4Z-L-1072

Loratadine Impurity 2

Ref: ST-EA-CP-L5032